NIH-funded research R21 grant

BipA’s role in Yersinia pestis causing pneumonic plague

Official title: Evaluating how BipA contributes to Yersinia pestis pathogenesis during pneumonic plague

Funded at East Carolina University · NIH-11452678 · Data updated 2026-11-12

A small NIH-funded project will explore how a bacterial protein called BipA helps Yersinia pestis cause severe lung infection in mice.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionEast Carolina University
NIH-funded
Lab location1 site (Greenville, United States)
Project startSeptember 2, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$223,957
NIH project number1R21AI192340-01A1
Project IDNIH-11452678 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with exposure to Yersinia pestis risk factors or those enrolled in infection biology studies, including basic-science cohorts or future clinical trials related to plague.

Less likely to help

Patients not involved in infectious-disease research or without exposure risk are unlikely to benefit from these basic mechanistic studies.

What this research studies

This grant will study BipA, a bacterial protein that helps Yersinia pestis stick to mammalian cells and resist parts of the immune system, to understand how it drives pneumonic plague. Researchers will use bacterial mutants and a mix of lab tests and mouse infection experiments to see what BipA does in the early stages of infection. They will also identify other proteins that BipA controls and that contribute to disease. The goal is to map the chain of events from BipA action to pathogenic outcomes in the lungs.

Why it matters

Potential benefit: Understanding BipA could point to new targets for vaccines or therapies to prevent or treat pneumonic plague.

How similar studies have gone: Past work on BipA-like regulators in other bacteria has shown they influence virulence, supporting the potential here but human outcomes remain to be demonstrated.

Where this research is happening

  • East Carolina University
    Greenville, United States
    Active

Researchers

  • Principal investigator: Pechous, Roger D — East Carolina University
  • Study coordinator: Pechous, Roger D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.